Skip to main content
. 2011 Sep;25(9):533–538. doi: 10.1089/apc.2011.0048

Table 1.

Bivariate Correlates of Patient Acceptance of Hepatitis C Virus Treatment

  Treatment accepted (n=79) Treatment refused (n=48)
Patient demographics
Male gendera 92% 77%
African Americanb 30% 46%
Mean agea (years) 48.1 51.2
Employed 37% 25%
Any college education 57% 58%
Currently in a relationship 26% 17%
HIV and HCV disease characteristics
Mean CD4 countc (mm3) 533 410
CD4 count≤200c 1% 21%
Mean log10 HIV RNA (copies/mL) 2.24 2.17
HIV RNA≤400 79% 83%
On ART 91% 96%
HCV genotype 1 or 4 72% 81%
Mean log10 HCV RNA (copies/mL) 6.09 6.24
Psychosocial functioning
Depression (past 6 months) 39% 44%
Other psychiatric disorder (past 6 months) 24% 20.8%
Frequent alcohol use (past 6 months) 8% 15%
Illicit drug use (past 6 months)a 11% 27%
Mean ART adherence 92% 87%
Any missed ART doses (past week) 23% 33%
Any missed clinic appointments (past 6 months) 34% 33%
Provider characteristics
Number of coinfected patientsc 309.6 132.0
Number of patients treated with IFN/RBVb 43.8 34.9
Treat with small amounts of alcohol is okayc 45% 19%
Treat only if patient's drug use stopped 44% 57%
Treat only if patient's depression is in remissiona 48% 64%
Confidence to treat HCVc 3.4 2.9
HCV treatment outcome expectationsa 4.3 4.0
a

p<0.05.

b

p<0.10.

c

p<0.01.

HCV, hepatitis C virus; ART, antiretroviral therapy; IFN/RBV, interferon/ribavirin.